date:Jul 30, 2021
ze SER-109, an investigational oral microbiome therapeutic in the US and Canada. If approved, SER-109 would become the first-ever microbiome therapeutic approved by the US Food and Drug Administration.
Coffee holds mammoth share of group sales
Growth was broad-based across most geographies, Nestl outlines. Organic growth was 6.7 percent in developed markets, based mostly on real internal growth (RIG). Organic growth in emerging markets was 10 percent, with strong RIG and positive pricing.
By p